Skip to main content
Clinical Trials/ACTRN12622000231741
ACTRN12622000231741
Completed
未知

Investigating the efficacy of a low calorie meal replacement dinner compared to traditional dinner meal on metabolic parameters of shift workers with obesity

Queensland University of Technology0 sites50 target enrollmentFebruary 9, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Queensland University of Technology
Enrollment
50
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 9, 2022
End Date
May 23, 2022
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • a)Permanent employees aged 18\-60 years
  • b)Have been working shifts continuously for past 12 months and continue during whole study period which is 8 weeks
  • c)Working at least 3 night shifts/week
  • d)Participants with BMI \>27\.5 kg/m2
  • e)Not having any allergies to any of the known food ingredients in the meal replacement

Exclusion Criteria

  • a)Pregnant or lactating mothers
  • b)Having known chronic disease conditions
  • c)History of any type of minor or major surgical procedure in the past 6 months.
  • d)Currently on diet prescriptions or participating regular physical activity sessions/programs ( e.g. yoga class)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Comparative study of the effects of a low caloric liquid diet versus a low caloric solid diet on the composition of the gut microbiome of healthy overweight/obese subjectsObesity ICD10 E66.00, E66.01OverweightE66.00E66.01
DRKS00016536Charité Campus Charité Mitte11
Completed
Not Applicable
The assesment of the effect of low calorie with moderate fiber diet on Brain-derived neurotrophic factor(BDNF) serum levels in obese and overweight type2 diabetic patients with different APO AII- 265T/C polymorphism
IRCT20180715040479N1Tehran University of Medical Sciences56
Recruiting
Not Applicable
Is it safe for obese patients on dialysis to lose weight using Optifast?ObesityChronic Kidney DiseaseDiet and Nutrition - ObesityRenal and Urogenital - Kidney disease
ACTRN12619000218190adia Obeid5
Completed
Not Applicable
Effect of weight loss on improvement of liver inflammation and fibrosis in non- alcoholic fatty liver patients through calorie restricted dieton-Alcoholic Fatty Liver - Non -Alcoholic Steatohepatitis.Other specified inflammatory liver diseases
IRCT2017081535707N1Vice Chancellor for research of Mashhad University of Medical Sciences60
Recruiting
Not Applicable
Adapting medical weight loss methods to the management of nonalcoholic fatty liver disease: A randomised control trial evaluating the effects of a very low energy diet on hepatic and metabolic outcomes in individuals with nonalcoholic fatty liver diseaseonalcoholic fatty liver diseaseNonalcoholic fatty liver diseaseOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
ACTRN12623000756628St Vincent's Hospital Melboourne24